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Abstract. Using a mouse protein tyrosine phosphatase rescence in situ hybridization. In an intronic region o f the IA-2
cDNA fragment as a probe, cosmid clones containing segments gene a polymorphic microsatellite sequence was found, which
of the hum an IA-2 PTPase gene (PTPRN) were isolated. The will be useful as a genetic m arker for the 2q35 —» q36 region, 
gene was assigned to chromosome region 2q35 -> q36.1 by fluo-
In recent years, protein tyrosine phosphatases (PTPases), tyrosine phosphatase domain, whereas the receptor-type
which oppose the actions of protein tyrosine kinases (PTKs), PTPases generally contain two tandemly repeated cytoplasmic
have gained attention as regulators of important cellular pro- tyrosine phosphatase domains. Exceptions are, for example,
cesses, such as cell growth and differentiation (Walton and Dix- PTP-SL (Hendriks et al., 1995) and IA-2 (Lan et a l ,  1994; Lu et
on, 1993). The phosphotyrosine content of cellular proteins is al., 1994), which are transm em brane proteins with only a single
determined by a balanced action of PTKs and PTPases; in tyrosine phosphatase domain.
some cases these enzymes have been shown to work in concert We mouse PTPase cDNA fragment,
in signal transduction networks, which carry signals from the mPTP38 (Hendriks et al., 1995), that was identical to se-
cell membrane to the nucleus (Brady-Kalnay and 
1994).
quences within mouse IA-2 cDNA (Lu et al., 1994). In this 
paper, we describe the use of m PTP38 as a probe to isolate
Until now, a substantial num ber of PTPase genes has been mouse full-length cDNAs and hum an genomic cosmid clones
identified, which can be classified into two large subgroups: for IA-2. The human IA-2 gene (PTPRN)
( 1) the cytosolic and nuclear PTPases and (2) the receptor-type chromosome region 2q35 —> q36 .1.
PTPases. As a rule, the cytosolic and nuclear PTPases have one
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Isolation o f  IA-2 cDNA and genomic clones
The 368-bp PCR fragment mPTP38 (Hendriks et al., 1995), was 
labeled radioactively by random priming and used as a probe to screen a 
mouse brain cDNA phage library (Stratagcne). Hybridization conditions 
were those as described by Hendriks et al. (1995). After hybridization, fil­
ters were washed two times at high stringency (0.1 % SDS, 0.04 M sodium 
phosphate [pH 7.4], 1 inM EDTA) for 20 min at 65 °C. Positively hybridiz­
ing phages were plaque-purified, and the inserts were rescued as pBlue-
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Fig. 1. Genomic sequence of part of the human PTP38/IA2 gene present in clone PTP3S/7.16S (GenBank accession No. 
Z48226). Exon sequences that correspond to nucleotides 2,462 to 2,572 in the IA-2 cDNA sequence (Lan et al., 1994) are in capital 
letters; intronic regions are depicted in lower-case letters. Above the exonic sequence the deduced amino acid sequence is shown in 
single letter notation. The sequence amplified by primer set F388 and R388 is underlined. The microsatellite is doubly under­
lined.
Script SK plasmids (Stratagene), following the instructions of the manufac- steps using rabbit-anti-FITC and mouse-anti-rabbit-FITC. A Zeiss epifluor-
turer, and sequenced. escence microscope was used for visual examination of the chromosome
The same mouse probe was used to screen a human genomic library in slides. Digital images were obtained using a high-performance cooled CCD 
cosmid vector Supercos 1, kindly provided by Dr Marten Hofker (University camera (Photometries) coupled to a Macintosh Ilci computer. The Oncor-
of Leiden, The Netherlands). Hybridization and washing conditions were as Image F.I.S.H. software package (Oncor-Imaging) was used for analysis of 
described above. the digital images.
Characterization o f a microsatellite al the human PTPRN locus 
Sau3A subclones from cosmid PTP38/7 were screened for the presence 
of microsatellite sequences by hybridizing recombinants-containing filters 
for 2 h at 37 °C in 5 x SSPE, 0.3% SDS with a mixture of oligonucleotides 
that were 5' end-labeled using [y-^PJATP and T4 polynucleotide kinase (Life 
Technologies). The oligonucleotide mixture consisted of 100 ng of oligonu­
cleotide (GA)7, (TG)7, (CAC)5, and (CTG)s, each. The insert of one positive 
clone (PTP38/7.16) was further shortened by Sstl digestion and self-ligation, 
yielding clone PTP38/7.16S, and sequenced.
Results and discussion
Polymerase chain reaction (PCR)
Based on sequence information in clone PTP38/7.16S, unique oligonu­
cleotides flanking the IA-2 microsatellite were designed and tested in a PCR, 
PCR was performed in a 50-p.l volume containing 40 ng of genomic DNA, 50
We recently isolated three novel mouse PTPase cDNA frag­
ments (Hendriks et al., 1995) using degenerate primers based 
on conserved catalytic domains in the rapidly expanding gene 
family (Walton and Dixon, 1993). One of these fragments, 
mPTP38 (Z23060), corresponds to a 4-kb transcript that is 
exclusively expressed in mouse brain (Hendriks et al., 1995). 
To obtain full-length cDNA clones, a mouse brain cDNA libra­
ry was screened using m PTP38 as a probe. In this way, a 3.6-kb
raM KC1, 20 mM Tris-HCl (pH 8.3), 1.0 mM MgCl2, 0.01 % gelatin, 0,1 % cDNA clone (PTP38-32) was isolated and sequenced entirely.
Triton-XlOO, and 100 ng of oligonucleotides F38 8 (5'-GGCCCTGCTCAT- While this work was nearing completion, the sequence of a 
GATTC-3' and R388 (5'-TCTATGAACGCTTTTTGACTC-3'). Oligonu­
cleotide F388 was 5' end-labeled with [y-32P]ATP and T4 polynucleotide 
kinase. After an initial denaturation step of 5 min at 950 C, 1 U of Taq poly-
mouse cDNA clone designated mIA-2 was published (Lu et al., 
1994) that appeared to be identical to our clone. The mouse
merase was added to the reaction mixture, and 32 cycles were performed; IA-2 cDNA also exhibits 92% identity with the published
each cycle involved denaturation at 940 C for 45 s, annealing at 430 C for 30 hum an IA-2 cDNA (Lan et al., 1994) that was isolated from an 
s, and elongation at 7 2 0 C for 40 s, with a final extension step of 5 min at 
720 C. PCR products were separated on 6 % denaturating polyacrylamide 
gels, and bands were visualized by autoradiography at - 8 0 0 C.
Fluorescence in situ hybridization (FISH)
Nonradioactive in situ hybridization to normal human lymphocyte 
metaphase spreads was performed essentially according to De Leeuw et al. 
(1993). Briefly, cosmid DNA (1 jag) was labeled with biotin-14-dATP (Life 
Technologies) by nick-translation, purified, and ethanol precipitated togeth­
er with a 50-fold excess of Cot-1 DNA (Life Technologies). Subsequently, 
250 ng was dissolved in 12 jj.1 of hybridization mixture consisting o f  2  x SSC,
10 % dextran sulfate, 1 % Tween-20, and 50 % formamide. The hybridization 
mixture was heat-denatured and then incubated overnight at 37 °C to heat- 
denatured chromosome spreads enclosed under a cover slip. Immunocyto- 
chcmical detection of the hybridizing probes was achieved using fluorescein
insulinoma subtraction library. Very recently, the putative rat 
homolog of IA-2, called PTPLP, has been reported to show 
98.4% homology in amino acid sequence with the intracellular 
part of the mIA-2 protein (Kambayashi et al., 1995).
Using cDNA fragment m PTP-38 as a probe, seven indepen­
dent, but overlapping, hum an IA-2 genomic cosmid clones 
(PTP38/1 through PTP38/7), spanning approximately 50 kb, 
were isolated. Their identity as PT PR N  gene-containing cos- 
mids was confirmed by sequence analysis o f an 0 .8-kb subclone 
(PTP38/7.16S), originating from cosmid PTP38/7, that con­
tains a region that is 100% identical to nucleotides 5,462 to 
2,572 of the IA-2 cDNA (Lan et al., 1994) (Fig. 1). In the same
isothiocyanate (FITC)-conjugated avidin, followed by two amplification subclone a microsatellite repeat o f 14 CA dinucleotides was
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Fig. 2. Chromosomal localization of the human PTPRN gene by FISH. 
The arrows indicate the location of the hybridization signals of the biotiny- 
lated probe (cosmid PTP38/7) to human metaphase chromosome spreads.
identified. Oligonucleotides flanking this repeat were designed tumors originating from tissues that normally express IA-2,
to amplify a segment of 163 bp and test the polymorphic value Frequent allelic losses of chromosome 2q have been reported in
of this microsatellite, using DNA of 37 unrelated Caucasian non-small cell lung carcinoma, colorectal carcinoma, and neu-
individuals. Four alleles were observed, with frequencies of roblastom a(Tsuchiyaetal., 1992; K ohnoet al., 1994; Shiseki et
0.054(167 bp), 0.20 (165 bp), 0.73 (163 bp), and 0.04 (161 bp), a l ,  1994), but involvement of PTPase IA-2 remains to beinves-
yielding a heterozygosity value o f 0.44. Thus, the polymorphic tigated. Although a potential tum or suppressor was suggested to
microsatellite repeat can serve as a genetic marker (D2S1753E) be homozygously deleted at region 2q 33 in a small cell lung
for the PTPRN  locus. carcinoma cell line (Kohno et a l ,  1994), based on our physical
The chromosomal localization o f hum an PTPRN  was deter- mapping data, the IA-2 locus appears to reside outside this
mined by FISH using cosmid PTP38/7 as a probe. Analysis o f region. The availability of a genetic marker at the PTPRN
40 human metaphase spreads revealed single hybridization sig- locus, as presented in this article, now enables loss of heterozy-
nals in the region 2q35-»q36.1 in almost all spreads and usual- gosity studies to evaluate whether IA-2 might be involved in
ly on both homologs (Fig. 2). This chromosomal localization these and/or other hum an tumors, 
was confirmed by FISH of two of the other isolated PTP38/
IA-2 cosmids, PTP38/4 and PTP38/6 (data not shown). We
therefore were able to assign the hum an gene for the PTPase 
IA-2 to chromosome region 2q35 -> q 3 6 .1.
Expression of hum an IA-2 m RN A  was observed in brain, 
pituitary and weakly in pancreatic tissue and enhanced expres­
sion of IA-2 mRNA was reported for pancreas-derived tumors, 
including insulinomas and a glucagonoma (Lan et al., 1994). 
This observation is suggestive o f a potential oncogenic effect 
resulting from elevated levels of IA-2 protein. Interestingly, for 
the human, mouse, and rat protein no PTPase activity could be 
demonstrated (Lan et al., 1994; Lu et al., 1994; Kambayashi et 
al., 1995), and it has been proposed that IA-2 might influence 
the proper interaction of other PTPase molecules with their 
respective substrates. However, a causative role of IA-2 in insu­
linoma and glucagonoma tumorigenesis, as well as the pro­
posed dephosphorylation inhibitory effect, remains to be dem­
onstrated .
On theoretical grounds, PTPases are expected to 
tum or suppressive potential. Therefore, we searched whether 
allelic loss of the 2q35-^q36.1  region has been reported in
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